219 related articles for article (PubMed ID: 34728497)
1. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E; Caballero-Ávila M; Martínez-Martínez L; Díaz-Manera J; Rojas-García R; Cortés-Vicente E; Turon-Sans J; de Luna N; Suárez-Calvet X; Gallardo E; Rajabally Y; Scotton S; Jacobs BC; Baars A; Cortese A; Vegezzi E; Höftberger R; Zimprich F; Roesler C; Nobile-Orazio E; Liberatore G; Hiew FL; Martínez-Piñeiro A; Carvajal A; Piñar-Morales R; Usón-Martín M; Albertí O; López-Pérez MÁ; Márquez F; Pardo-Fernández J; Muñoz-Delgado L; Cabrera-Serrano M; Ortiz N; Bartolomé M; Duman Ö; Bril V; Segura-Chávez D; Pitarokoili K; Steen C; Illa I; Querol L
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728497
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies.
Zhang J; Hou X; Wei L; Liu J; Li S; Guo Y; Liu H; Jiang Y
Front Immunol; 2024; 15():1345953. PubMed ID: 38726012
[TBL] [Abstract][Full Text] [Related]
3. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
4. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
5. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
Bai Y; Li W; Yan C; Hou Y; Wang Q
Front Immunol; 2023; 14():1121705. PubMed ID: 37056784
[TBL] [Abstract][Full Text] [Related]
6. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
[TBL] [Abstract][Full Text] [Related]
9. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
[TBL] [Abstract][Full Text] [Related]
10. Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study.
Vallat JM; Mathis S; Magy L; Bounolleau P; Skarzynski M; Heitzmann A; Manso C; Devaux J; Uncini A
Brain; 2018 Jul; 141(7):e56. PubMed ID: 29800077
[No Abstract] [Full Text] [Related]
11. Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies.
Ren Y; Chen S; Yang H
Front Immunol; 2023; 14():1279808. PubMed ID: 37965304
[TBL] [Abstract][Full Text] [Related]
12. Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy.
Liu L; Chen J; Zhang Y; Wu J; Hu J; Lin Z
Front Immunol; 2022; 13():986018. PubMed ID: 36211443
[TBL] [Abstract][Full Text] [Related]
13. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
[TBL] [Abstract][Full Text] [Related]
14. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
15. Paranodal and other autoantibodies in chronic inflammatory neuropathies.
Querol L; Illa I
Curr Opin Neurol; 2015 Oct; 28(5):474-9. PubMed ID: 26263474
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of anti-neurofascin-155 antibodies in patients with neuromyelitis optica spectrum disorders.
Chang SH; Wang J; Zhang X; Zhao N; Jia K; Yi M; Zhang QX; Zhai H; Li XW; Yang CS; Yang L; Zhang LJ
Clin Exp Immunol; 2021 Oct; 206(1):1-11. PubMed ID: 33998675
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against nodo-paranodal proteins are not present in genetic neuropathies.
Martín-Aguilar L; Pascual-Goñi E; Lleixà C; Frasquet M; Argente H; Cano-Abascal A; Diaz-Manera J; Cortés-Vicente E; Pelayo-Negro AL; Sevilla T; Rojas-García R; Querol L
Neurology; 2020 Jul; 95(4):e427-e433. PubMed ID: 32102977
[TBL] [Abstract][Full Text] [Related]
18. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody.
Liu B; Zhou L; Sun C; Wang L; Zheng Y; Hu B; Qiao K; Zhao C; Lu J; Lin J
Ann Clin Transl Neurol; 2023 Jun; 10(6):944-952. PubMed ID: 37060203
[TBL] [Abstract][Full Text] [Related]
20. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
